Novartis Needs Board Shakeup and M&A Revamp, Investor Says

Shareholder Artisan Partners called for Novartis AG to change its board composition and improve its mergers and acquisitions strategy after the company's stock price fell following three clinical trial failures, according to Reuters.

Next story